Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Decibel Cannabis CoTSXV:DB -4.55%42 Debt-to-EBITDA is 38.76 as of Mar. 2026, which is 1623% above its 10-year median of 2.25. GuruFocus rates TSXV:DB with a GF Score™ of 42/100 and a GF Value™ of C$0.11 (Fairly Valued). The stock has 6 warning signs investors should review. Among 689 Drug Manufacturers companies, Decibel Cannabis Co ranks worse than 91.58% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Decibel Cannabis Co's Debt-to-EBITDA or its related term are showing as below:
TSXV:DB'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -11.3 Med: 2.25 Max: 21.41
Current: 9.28
During the past 13 years, the highest Debt-to-EBITDA Ratio of Decibel Cannabis Co was 21.41. The lowest was -11.30. And the median was 2.25.
TSXV:DB's Debt-to-EBITDA is ranked worse than 91.58% of 689
companies
in the Drug Manufacturers industry
Industry Median: 1.64
vs TSXV:DB: 9.28
Decibel Cannabis Co (TSXV:DB) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Decibel Cannabis Co Debt-to-EBITDA Related Terms
Decibel Cannabis Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Decibel Cannabis Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Decibel Cannabis Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Decibel Cannabis Co Debt-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Decibel Cannabis Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Decibel Cannabis Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Decibel Cannabis Co (TSXV:DB) has a Debt-to-EBITDA of 38.76 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Decibel Cannabis Co. This is 1623% above median its historical median of 2.25. According to the industry distribution chart, Decibel Cannabis Co ranks #631 out of 689 companies in the Drug Manufacturers industry, placing it in the top 91.6%.
Is Decibel Cannabis Co's Debt-to-EBITDA too high?
Decibel Cannabis Co's current Debt-to-EBITDA of 38.76 is 1623% above median its 10-year median of 2.25. The Drug Manufacturers industry median Debt-to-EBITDA is 1.64. Decibel Cannabis Co's value of 38.76 is 2263.4% above this industry median. Based on the distribution chart, Decibel Cannabis Co ranks #631 out of 689 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Decibel Cannabis Co has a GF Score™ of 42/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Decibel Cannabis Co's Debt-to-EBITDA compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Decibel Cannabis Co ranks #631 out of 689 companies for Debt-to-EBITDA. This places Decibel Cannabis Co in the lower half of its industry. The industry median Debt-to-EBITDA is 1.64. Decibel Cannabis Co's value of 38.76 is 2263.4% above this benchmark. While the company's 10-year median is 2.25 vs. the industry median of 1.64, Decibel Cannabis Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Drug Manufacturers company?
The median Debt-to-EBITDA among Drug Manufacturers companies is 1.64, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Decibel Cannabis Co's current Debt-to-EBITDA of 38.76 is 2263.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Decibel Cannabis Co. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Decibel Cannabis Co's current Debt-to-EBITDA is 38.76, which is 1623% above median its own 10-year median of 2.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Decibel Cannabis Co stock overvalued right now?
Based on GuruFocus' analysis, Decibel Cannabis Co (TSXV:DB) is currently considered Fairly Valued. The stock's GF Value™ is C$0.11, compared to a current price of C$0.11 — trading 4.5% below its estimated fair value. The current Debt-to-EBITDA is 38.76, which is 1623% above median its 10-year median of 2.25 and 2263.4% above the Drug Manufacturers industry median of 1.64. Decibel Cannabis Co's overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Decibel Cannabis Co (TSXV:DB), the current Debt-to-EBITDA is 38.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Decibel Cannabis Co (TSXV:DB) Overvalued in 2026?
Based on GuruFocus' analysis, Decibel Cannabis Co stock appears to be undervalued.
The current stock price of C$0.11 is trading 4.5% below its estimated GF Value™ of C$0.11.
GuruFocus considers Decibel Cannabis Co to be Fairly Valued.
Key valuation signals for TSXV:DB:
Debt-to-EBITDA: 38.76 (1623% above median its 10-year median of 2.25)
GF Value™: C$0.11 vs. price of C$0.11 (4.5% below fair value)
Industry Position: 2263.4% above the Drug Manufacturers median (#631 of 689)
No single metric tells the full story. See the TSXV:DB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Decibel Cannabis Co Inc is engaged in the cannabis operations business. The company is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers and the direct sale of products through its retailer locations to end customers.
42GF Score
Get the complete analysis for TSXV:DB
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:DB has been successfully added to your 
